Screening for C3 deficiency in newborns using microarrays

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Janzi, Magdalena ^a   Sjöberg, Ronald ^b   Wan, Jinghong ^b   Fischler, Björn ^c   von Döbeln, Ulrika ^a   Isaac, Lourdes ^d   Nilsson, Peter ^b   Hammartström, Lennart ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ALBANOVA UNIVERSITY CENTER   (Sweden)

^c KUS Huddinge   (Sweden)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A;

ARTICLE; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PATIENT IDENTIFICATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN MICROARRAY; METHODOLOGY;

COMPLEMENT C3; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PROTEIN ARRAY ANALYSIS;

EID: 65449143570     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005321     Document Type: Article

References (23)

1. International Union of Immunological Societies (1999) Primary immunodeficiency diseases: report of an IUIS Scientific Committee. Clin Exp Immunol 118(Suppl 1): 1-28.
2. Sjöholm AG, Jönsson G, Braconier JH, Sturfelt G, Truedsson L (2006) Complement deficiency and disease: an update. Mol Immunol 43: 78-85.
3. Reis ES, Falcão DA, Isaac L (2006) Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol 63: 155-168.
4. Singer L, Colten HR, Wetsel RA (1994) Complement C3 deficiency: human, animal, and experimental models. Pathobiology 62: 14-28.
5. Fujioka H, Ariga T, Yoda M, Ohsaki M, Horiuchi K, et al. (2005) A case of C3 deficiency with a novel homozygous two-base deletion in the C3 gene. Am J Med Genet A 138: 399-400.
6. Kida M, Fujioka H, Kosaka Y, Hayashi K, Sakiyama Y, et al. (2008) The first confirmed case with C3 deficiency caused by compound heterozygous mutations in the C3 gene; a new aspect of pathogenesis for C3 deficiency. Blood Cells Mol Dis 40: 410-413.
7. Ghannam A, Pernollet M, Fauquert JL, Monnier N, Ponard D, et al. (2008) Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells. J Immunol 181: 5158-5166.
8. Botto M, Fong KY, So AK, Rudge A, Walport MJ (1990) Molecular basis of hereditary C3 deficiency. J Clin Invest 86: 1158-1163.
9. Botto M, Fong KY, So AK, Barlow R, Routier R, et al. (1992) Homozygous hereditary C3 deficiency due to a partial gene deletion. Proc Natl Acad Sci U S A 89: 4957-4961.
10. Singer L, Whitehead WT, Akama H, Katz Y, Fishelson Z, et al. (1994) Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (ASP549 to ASN) impairs C3 secretion. J Biol Chem 269: 28494-28499.
11. Huang JL, Lin CY (1994) A hereditary C3 deficiency due to aberrant splicing of exon 10. Clin Immunol Immunopathol 73: 267-273.
12. Matsuyama W, Nakagawa M, Takashima H, Muranaga F, Sano Y, et al. (2001) Identification of a novel mutation (Tyr1081Ter) in sisters with hereditary component C3 deficiency and SLE-like symptoms. Hum Mutat 17: 79.
13. Reis ES, Baracho GV, Sousa Lima A, Farah CS, Isaac L (2002) Homozygous hereditary C3 deficiency due to a premature stop codon. J Clin Immunol 22: 321-330.
14. Reis ES, Nudelman V, Isaac L (2004) Nonsense-codon-mediated decay in human hereditary complement C3 deficiency. Immunogenetics 55: 667-673.
15. Tsukamoto H, Horiuchi T, Kokuba H, Nagae S, Nishizaka H, et al. (2005) Molecular analysis of a novel hereditary C3 deficiency with systemic lupus erythematosus. Biochem Biophys Res Commun 330: 298-304.
16. McDade TW, Williams S, Snodgrass JJ (2007) What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 44: 899-925.
17. Skogstrand K, Thorsen P, Nørgaard-Pedersen B, Schendel DE, Sørensen LC, et al. (2005) Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 51: 1854-1866.
18. Jeffrey Modell Foundation breaking news: Newborn screening for primary immunodeficiencies (2009) http://www.info4pi.org/ newsletters_publications/index.cfm?section=newspubs&content= breakingnews&newsid=197&CFID=32118322&CFTOKEN=51295278 Accessed 13 January 2009.
19. Janzi M, Odling J, Pan-Hammarström Q, Sundberg M, Lundeberg J, et al. (2005) Serum microarrays for large scale screening of protein levels. Mol Cell Proteomics 4: 1942-1947.
20. Lannergård A, Fohlman J, Wesslén L, Rolf C, Friman G (2001) Immune function in Swedish elite orienteers. Scand J Med Sci Sports 11: 274-279.
21. Ulbrich AG, Florido MP, Nudelman V, Reis ES, Baracho GV, et al. (2001) Hereditary human complement C3 deficiency owing to reduced levels of C3 mRNA. Scand J Immunol 53: 622-626.
22. Chan K, Puck JM (2005) Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 115: 391-398.
23. Ingvarsson J, Larsson A, Sjöholm AG, Truedsson L, Jansson B, et al. (2007) Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins. J Proteome Res 6: 3527-3536.